top of page
TheCellStation
News,
Events &
Insights

Insights
Explore in-depth articles and analysis from our team. We share our perspectives on the industry's most important topics and challenges.


Engineering Clinical Relevance: Why NAMs Are More Than Animal Replacement
Image generated using Google Gemini (because an actual mouse in the lab isn't as cute!) Beyond the Ethics Argument The conversation around New Approach Methodologies (NAMs) often centers on two points: animal welfare and the poor predictivity of animal models for human outcomes. Both are valid. Both matter. But they miss the most compelling reason to adopt human iPSC-based systems: we can engineer models where the experimental readouts directly match clinical endpoints. This
Dec 18, 2025


Industry Insight: The Hidden Cost of Variable Cardiomyocytes - A $2.6 Billion Problem
Published on Celogics Inc. Blog - The Cell Station | September 18, 2025 In pharmaceutical boardrooms around the world, executives grapple...
Sep 18, 2025


The Art and Science of Making "Good" Cardiomyocytes: Why Heart Cells Are the Ultimate Cell Engineering Challenge
Published on Celogics Inc. Blog - The Cell Station | Aug 27, 2025 "What makes a good cardiomyocyte?" It's a question that sounds...
Aug 27, 2025


iPSC-Therapies: How 18 Years of Development Reached the Commercial Inflection Point
Published on Celogics.com | Aug 21, 2025 Eighteen years after Shinya Yamanaka's groundbreaking discovery of induced pluripotent stem...
Aug 21, 2025


The Genomics Revolution: How Economies of Scale Are Making Personalized Medicine Accessible to All
Published on www.Celogics.com TheCellStation | Aug 13, 2025 The healthcare industry stands at an inflection point. What began as a...
Aug 13, 2025


Recent FDA Approvals & Designations Signal New Era for Cell Therapy Innovation
Published on celogics.com | Aug 12, 2025 The biotechnology landscape is experiencing a remarkable transformation, and the latest FDA...
Aug 11, 2025
bottom of page